BET inhibitors also synergize with targeted radiotherapy, as shown by combination with the PSMA-directed alpha-emitting radioligand [212Pb]Pb-AB001, which further suppresses prostate cancer growth in vitro (177). This evidence concerns the gene DNER and prostate carcinoma.